glp-1 and type 1 diabetes receptor agonists are increasingly used to treat 2 obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Frontiers | Glucagon-like peptide-1 receptor

In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation

CALIFORNIA WARNING: Can expose you to lead, a reproductive toxicant

Disruption of Melatonin Signaling Leads to Lipids Accumulation in the Liver of [PMID: 39539075] Laboratory literature summary: Disruption of Melatonin Signaling Leads to Lipids Accumulation in the Liver of Melatonin Proficient Mice

Maintaining adequate vitamin D year-round through blood work to assess levels and supplementation when needed can therefore be relevant to hormonal health

Landmark clinical trials show GLP-1 users lose 15-22% of body weight over 68 weeks, compared to 2-3% with lifestyle changes alone